(3-(4-Fluorophenyl)-11-methyl-6, 11-dihydro-5H-indolizino[8,7-b]indole-1,2-diyl)dimethanol

ID: ALA4082441

PubChem CID: 137645784

Max Phase: Preclinical

Molecular Formula: C23H21FN2O2

Molecular Weight: 376.43

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1c2c(c3ccccc31)CCn1c(-c3ccc(F)cc3)c(CO)c(CO)c1-2

Standard InChI:  InChI=1S/C23H21FN2O2/c1-25-20-5-3-2-4-16(20)17-10-11-26-21(14-6-8-15(24)9-7-14)18(12-27)19(13-28)23(26)22(17)25/h2-9,27-28H,10-13H2,1H3

Standard InChI Key:  ZKLVXXYYYBADCG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
    9.4984   -9.5408    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9771   -8.8795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4996   -8.2184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7214   -8.4658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0181   -8.0584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3073   -8.4641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3040   -9.2813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0114   -9.6928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7222   -9.2829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3962   -9.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1069   -8.9393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9395   -8.1402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1253   -8.0487    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6478   -7.3876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8330   -7.4725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7920   -8.7988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4857   -7.5319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2383   -6.7536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7845   -6.1494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5863   -6.3193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8337   -7.0975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2875   -7.7059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1325   -5.7151    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.3088  -10.1592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9701  -10.6379    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8529   -9.2726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5140   -8.7952    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7490  -10.3186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  1  9  1  0
  4  9  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 10 16  2  0
 13 16  1  0
  2 16  1  0
  3 15  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 17 22  2  0
 20 23  1  0
 12 17  1  0
 24 25  1  0
 10 24  1  0
 26 27  1  0
 11 26  1  0
  1 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4082441

    ---

Associated Targets(Human)

CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H526 (216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H211 (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP1 Tclin DNA topoisomerase I (7553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP2A Tclin DNA topoisomerase II alpha (6317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 376.43Molecular Weight (Monoisotopic): 376.1587AlogP: 3.99#Rotatable Bonds: 3
Polar Surface Area: 50.32Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.30CX LogD: 3.30
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.57Np Likeness Score: -0.24

References

1. Chang SM, Christian W, Wu MH, Chen TL, Lin YW, Suen CS, Pidugu HB, Detroja D, Shah A, Hwang MJ, Su TL, Lee TC..  (2017)  Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities.,  127  [PMID:28064078] [10.1016/j.ejmech.2016.12.046]

Source